Selected – 2014

Transnational Joint Call for proposals on human infectious diseases through the ERA-NET Infect-ERA

The ANR joins the ERA-NET Infect-ERA to launch a second transnational call for funding research on human infectious diseases. This programme is a continuation of ERA-NET PathoGenoMics.

Twelve countries are participating in this call for proposals: Austria, Belgium, France, Germany, Hungary, India, Israel, Poland, Portugal, Romania, Spain and Sweden.

Through this call, Infect-ERA aims to fund transnational and translational research, bringing together basic, applied, technology-driven and clinical research approaches of a broad variety of research topics regarding human infectious diseases. The call will enable multinational, collaborative research projects addressing specific topics of human infectious diseases caused by bacteria, virus, fungi or protozoa.
Transnational research consortia are invited to submit proposals related with at least one of the following themes, which are equal in relevance for this call:

  • A. Assess the role of commensal flora in homeostasis and microbe’s pathogenicity, and elucidate how commensal organisms or probiotics can be used to prevent or treat infections.
  • B. Development and application of new techniques to investigate the initial steps of the infection process.

To address these themes, the proposals should integrate one of the following approaches:

  • (i) Application of novel approaches and technologies such as metagenomics, transcriptomics, and metabolomics.
  • (ii) Integration of new approaches to understand the effect of the pathogen upon infection and to develop biomarkers, preventive, diagnostic and therapeutic tools.

Proposals focusing on HIV/AIDS, hepatitis B/C, malaria and tuberculosis are not in the scope of the call.

Each project proposal (pre- and full proposal) must involve a maximum of six (6) partners from at least three (3) participating countries (maximum of two (2) partners per country). The minimum of three (3) partners must be eligible for the funding organisations of three different countries participating in this call (see list in the call text).

The proposals should favourably show a close collaboration between academic and clinical and/or industrial participants, convincingly present the application (exploitation) of the project results, and demonstrate a clear benefit to the public.

Non-funded project partners may also be part of the consortia if they are able to clearly demonstrate an added value to the consortium and secure their own funding. However, the coordinator and the majority of partners in a consortium must be eligible for the funding organisations participating in this call, and the maximum number of six participants may not be exceeded in any case. If one of the partners is not eligible the proposal will be rejected without further review.

Part of the available funding is dedicated especially to consortia of young scientists. Each project leader of such consortia must be a “young scientist”, which is defined as having been awarded a PhD or equivalent at least two and a maximum of nine years before the deadline for submission of pre-proposals (periods of maternity/paternity leave or military service shall be taken into account).

Funding will be awarded for a maximum of three years. The ANR will fund only the French partners in the selected projects.

Open
Closed
Opening : 2014-01-17 at 18h27 CET
Application Deadline : 2014-04-02 at 17h00 CEST

This call will be managed by the Infect-ERA call office, which is based in Madrid, Spain.

Submissions of proposals will be in two steps. All proposals should be submitted online via the submission website before the respective deadlines (pre-proposals April 2nd, 2014, 17:00 CET; full proposals August 4th, 2014, 17:00 CET). Only invited pre-proposals will be accepted for full proposal submission.

Each French partner of the selected projects will sign a grant agreement with the ANR.

CONTACT

Infect-ERA call office

Mrs. Irene Sánchez
infect-era(at)mineco.es
Phone: +34 916038241

ANR